<DOC>
	<DOCNO>NCT02290548</DOCNO>
	<brief_summary>The purpose study determine whether high flow nasal cannula effective lowering reintubation rate extubation high risk patient medical intensive care unit</brief_summary>
	<brief_title>Effect High-flow Nasal Oxygen Extubation Outcome</brief_title>
	<detailed_description>The study hypothesis Optiflow may reduce extubation failure rate high risk patient medical intensive care unit.In intervention group , patient fulfil inclusion criterion present exclusion criterion receive high-flow nasal cannula ( Optiflow Airvo2 , Fisher &amp; Paykel Healthcare Ltd. , New Zealand ) extubation . The oxygen concentration ( FiO2 ) set reach oxygenation target similar control patient ( see ) , gas flow rate set 50 L/min.In control group , patient fulfil inclusion criterion present exclusion criterion receive standard oxygen therapy include nasal cannula oxygen mask extubation . The FiO2 set obtain arterial oxygen saturation ( SpO2 ) 92 % 98 % ( 88 % 95 % hypercapnic patient ) . NIPPV intubation apply group respiratory distress note . High flow nasal cannula try NIPPV intubation control group patient .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>Patients mechanically ventilate &gt; 48 hour least one following : &gt; 65 y/o Cardiac failure primary indication mechanical ventilation COPD Bronchiectasis Old pulmonary tuberculosis destructive lung Chronic renal failure Neuromuscular disease BMI &gt; 30 Inability manage respiratory secretion ARDS Presence tracheostomy Recent facial trauma Active gastrointestinal bleeding Planned NIPPV support extubation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>high flow nasal cannula</keyword>
	<keyword>extubation failure</keyword>
</DOC>